secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001615219-25-000064
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius gets Nasdaq extension to regain listing compliance; milestones set for July/August 2025
--------------------------------------------------------------------------------

- Nasdaq Hearings Panel granted extension to comply with Minimum Bid Price and Equity Standards.
- Must regain compliance with Equity Standard (minimum $2.5M stockholders' equity) by early July 2025.
- Must regain compliance with Minimum Bid Price (closing bid $1.00) by early August 2025.
- Previously received delisting notices for non-compliance with both rules; hearing held June 3, 2025.
- Failure to meet milestones may result in revocation of extension and delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000064/0001615219-25-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000064/flks-20250611.htm
  HTML page:      https://secwatch.observer/filing/0001615219-25-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer